id,input,output
0,"Sepsis is an aggressive and life-threatening organ dysfunction induced by infection. Excessive inflammation and coagulation contribute to the negative outcomes for sepsis, resulting in high morbidity and mortality. In this study, we explored whether Eupatilin could alleviate lung injury, reduce inflammation and coagulation during sepsis.","[{'entity1': 'Sepsis', 'relationship': 'organ dysfunction', 'entity2': 'Infection'}, {'entity1': 'Inflammation', 'relationship': 'contribute to', 'entity2': 'Negative outcomes'}, {'entity1': 'Inflammation', 'relationship': 'contribute to', 'entity2': 'High morbidity'}, {'entity1': 'Inflammation', 'relationship': 'contribute to', 'entity2': 'Mortality'}, {'entity1': 'Eupatilin', 'relationship': 'alleviate', 'entity2': 'Lung injury'}, {'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'Inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'Coagulation'}]"
1,"We constructed an in vitro sepsis model by stimulating RAW264.7 cells with 1 μg/mL lipopolysaccharide (LPS) for 6 hours. The cells were divided into control group, LPS group, LPS+ Eupatilin (Eup) group, and Eup group to detect their cell activity.","[{'entity1': 'RAW264.7 cells', 'relationship': 'stimulating', 'entity2': 'Lipopolysaccharide (LPS)'}, {'entity1': 'LPS', 'relationship': 'model', 'entity2': 'Sepsis'}, {'entity1': 'LPS', 'relationship': 'stimulating', 'entity2': 'RAW264.7 cells'}, {'entity1': 'Eupatilin', 'relationship': 'treatment', 'entity2': 'Sepsis'}, {'entity1': 'Eupatilin', 'relationship': 'affect', 'entity2': 'Cell activity'}]"
2,"Sepsis is a life-threatening organ dysfunction caused by infection, which results from dysregulated host response. A study reported in Lancet showed that sepsis remains a major cause of health loss worldwide, with 48.9 million cases each year and approximately 11 million deaths, which accounts around one-fifth of the total global deaths. According to Nature Reviews Disease Primers, more than half of sepsis patients are complicated with coagulation system imbalance. Moreover, in patients who have sepsis with disseminated intravascular coagulation (DIC) the mortality rate is almost twice that of sepsis patients without DIC. Therefore, reducing inflammation and coagulation disorders could be the key to reducing sepsis mortality.","[{'entity1': 'Sepsis', 'relationship': 'organ dysfunction', 'entity2': 'Infection'}, {'entity1': 'Sepsis', 'relationship': 'cause', 'entity2': 'Dysregulated host response'}, {'entity1': 'Sepsis', 'relationship': 'complicated with', 'entity2': 'Coagulation system imbalance'}, {'entity1': 'Sepsis', 'relationship': 'complicated with', 'entity2': 'Disseminated intravascular coagulation'}, {'entity1': 'DIC', 'relationship': 'complication of', 'entity2': 'Sepsis'}, {'entity1': 'Inflammation', 'relationship': 'reducing', 'entity2': 'Sepsis mortality'}, {'entity1': 'Coagulation disorders', 'relationship': 'reducing', 'entity2': 'Sepsis mortality'}]"
3,Eupatilin may modulate inflammation and coagulation indicators as well as improve lung injury in sepsis via the JAK2/STAT3 signaling pathway.,"[{'entity1': 'Eupatilin', 'relationship': 'modulate', 'entity2': 'Inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'modulate', 'entity2': 'Coagulation indicators'}, {'entity1': 'Eupatilin', 'relationship': 'improve', 'entity2': 'Lung injury'}, {'entity1': 'Eupatilin', 'relationship': 'act via', 'entity2': 'JAK2/STAT3 signaling pathway'}]"
4,"Tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and tissue factor (TF) expression in LPS-stimulated RAW264.7 cells was downregulated by Eupatilin (10μM).","[{'entity1': 'Tumor necrosis factor', 'relationship': 'downregulated by', 'entity2': 'Eupatilin'}, {'entity1': 'Interleukin', 'relationship': 'downregulated by', 'entity2': 'Eupatilin'}, {'entity1': 'IL-6', 'relationship': 'downregulated by', 'entity2': 'Eupatilin'}, {'entity1': 'Tissue factor', 'relationship': 'downregulated by', 'entity2': 'Eupatilin'}, {'entity1': 'RAW264.7 cells', 'relationship': 'stimulated by', 'entity2': 'LPS'}]"
5,"Macrophages are involved in various pathophysiological processes in sepsis, including inflammation, coagulation, immunity and metabolism, and play a crucial role in sepsis-induced acute lung injury. In the early stages of sepsis, macrophages engulf pathogens and activate the innate immune system.","[{'entity1': 'Macrophages', 'relationship': 'involved', 'entity2': 'pathophysiological processes'}, {'entity1': 'Macrophages', 'relationship': 'role', 'entity2': 'sepsis-induced acute lung injury'}, {'entity1': 'Macrophages', 'relationship': 'engulf', 'entity2': 'pathogens'}, {'entity1': 'Macrophages', 'relationship': 'activate', 'entity2': 'innate immune system'}]"
6,"Lipopolysaccharide (LPS), an important cell wall constituent of Gram-negative bacteria, is a potent inducer of inflammatory responses. After exposure to LPS, macrophages produce large amounts of inflammatory cytokines, interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF.","[{'entity1': 'Lipopolysaccharide', 'relationship': 'inducer', 'entity2': 'inflammatory responses'}, {'entity1': 'LPS', 'relationship': 'exposure', 'entity2': 'macrophages'}, {'entity1': 'Macrophages', 'relationship': 'produce', 'entity2': 'inflammatory cytokines'}]"
7,"Eupatilin (Eup) is a lipophilic flavonoid isolated from Artemisia argyi, which has the effect of warming the meridian to stop bleeding, dispersing cold and relieving pain. In recent years, Eupatilin has been found to have biological activities against inflammation, oxidation, and tumors.","[{'entity1': 'Eupatilin', 'relationship': 'isolated', 'entity2': 'Artemisia argyi'}, {'entity1': 'Eupatilin', 'relationship': 'effect', 'entity2': 'warming the meridian'}, {'entity1': 'Eupatilin', 'relationship': 'activities against', 'entity2': 'inflammation'}]"
8,"Eupatilin can reduce the inflammatory response in LPS-induced rats, decreasing the level of surfactant protein (SP)-A, SP-D, and inflammatory factors.","[{'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'inflammatory response'}, {'entity1': 'Eupatilin', 'relationship': 'decreasing', 'entity2': 'level'}, {'entity1': 'Eupatilin', 'relationship': 'decreasing', 'entity2': 'surfactant protein A'}, {'entity1': 'Eupatilin', 'relationship': 'decreasing', 'entity2': 'surfactant protein D'}]"
9,Eupatilin can reduce the number of inflammatory cells in OVA-induced asthmatic mice and inhibit the NF-κB and MAPK pathways.,"[{'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'number of inflammatory cells'}, {'entity1': 'Eupatilin', 'relationship': 'inhibit', 'entity2': 'NF-κB pathway'}, {'entity1': 'Eupatilin', 'relationship': 'inhibit', 'entity2': 'MAPK pathway'}]"
10,Eupatilin can inhibit arachidonic acid (AA)-induced platelet aggregation and thromboxane A2 (TXA2) generation.,"[{'entity1': 'Eupatilin', 'relationship': 'inhibit', 'entity2': 'platelet aggregation'}, {'entity1': 'Eupatilin', 'relationship': 'inhibit', 'entity2': 'thromboxane A2 generation'}]"
11,Eupatilin can exert anti-inflammatory and anti-coagulation effects in LPS-induced RAW264.7 macrophages and CLP mouse model by suppressing the JAK2/STAT3 signaling pathway.,"[{'entity1': 'Eupatilin', 'relationship': 'exert', 'entity2': 'anti-inflammatory effects'}, {'entity1': 'Eupatilin', 'relationship': 'exert', 'entity2': 'anti-coagulation effects'}, {'entity1': 'Eupatilin', 'relationship': 'suppressing', 'entity2': 'JAK2/STAT3 signaling pathway'}]"
12,"Eupatilin (10 μM) was applied to RAW264.7 cells for 2 hours, followed by a 6-hour stimulation with LPS (1 μg/mL).","[{'entity1': 'Eupatilin', 'relationship': 'applied to', 'entity2': 'RAW264.7 cells'}, {'entity1': 'RAW264.7 cells', 'relationship': 'stimulation with', 'entity2': 'LPS'}]"
13,"RAW264.7 macrophages were purchased from ATCC (Manassas, VA, USA) and cultivated in DMEM with 10% FBS.","[{'entity1': 'RAW264.7 macrophages', 'relationship': 'purchased from', 'entity2': 'ATCC'}, {'entity1': 'RAW264.7 macrophages', 'relationship': 'cultivated in', 'entity2': 'DMEM'}]"
14,The LPS group was stimulated with 1 μg/mL LPS for 6 hours.,"[{'entity1': 'LPS group', 'relationship': 'stimulated with', 'entity2': 'LPS'}]"
15,"The Eup group was treated only with 10 μM Eupatilin, which was added the same time as LPS+ Eup group.","[{'entity1': 'Eup group', 'relationship': 'treated with', 'entity2': 'Eupatilin'}, {'entity1': 'Eup group', 'relationship': 'added with', 'entity2': 'LPS+ Eup group'}]"
16,The effects of Eupatilin on the proliferation of RAW264.7 macrophages were assessed using the CCK-8 assay.,"[{'entity1': 'Eupatilin', 'relationship': 'affects', 'entity2': 'proliferation'}, {'entity1': 'RAW264.7 macrophages', 'relationship': 'assessed by', 'entity2': 'CCK-8 assay'}]"
17,"The day before stimulation, RAW264.7 cells were seeded in a 96-well plate at a density of 1.0×104 cells/well.","[{'entity1': 'RAW264.7 cells', 'relationship': 'seeded in', 'entity2': '96-well plate'}, {'entity1': 'RAW264.7 cells', 'relationship': 'density', 'entity2': '1.0×104 cells/well'}]"
18,"The RT-qPCR was performed using SYBR Green on a PCR detection system (7500fast, USA).","[{'entity1': 'RT-qPCR', 'relationship': 'performed using', 'entity2': 'SYBR Green'}, {'entity1': 'PCR detection system', 'relationship': 'used for', 'entity2': 'RT-qPCR'}]"
19,We obtained male C57BL/6 mice at the age of 6–8 weeks and the weight of 18–25 g from Shanghai SLAC Laboratory.,"[{'entity1': 'Male C57BL/6 mice', 'relationship': 'obtained from', 'entity2': 'Shanghai SLAC Laboratory'}, {'entity1': 'Male C57BL/6 mice', 'relationship': 'age', 'entity2': '6–8 weeks'}, {'entity1': 'Male C57BL/6 mice', 'relationship': 'weight', 'entity2': '18–25 g'}]"
20,"The mice were randomly assigned into three groups according to the random number table method: sham operation (SHAM) group, CLP group, CLP + Eup group. After the processing time, each group contained more than six samples. The mice were anesthetized by 1% sodium pentobarbital (Solarbio, China) according to their weight (100 μL/10 g) before operation.","[{'entity1': 'mice', 'relationship': 'assigned', 'entity2': 'groups'}, {'entity1': 'groups', 'relationship': 'contained', 'entity2': 'samples'}, {'entity1': 'mice', 'relationship': 'anesthetized', 'entity2': 'sodium pentobarbital'}, {'entity1': 'sodium pentobarbital', 'relationship': 'administered', 'entity2': 'mice'}]"
21,"After the mice were anesthetized, we opened the abdominal cavity and carefully exposed the cecum, which was then ligated at 1 cm from the end and punched through by a needle (21-gauge). Subsequently, the feces were squeezed out into the abdomen and the cecum was placed back. Finally, the abdominal cavity was closed.","[{'entity1': 'mice', 'relationship': 'exposed', 'entity2': 'cecum'}, {'entity1': 'cecum', 'relationship': 'ligated', 'entity2': 'end'}, {'entity1': 'cecum', 'relationship': 'punched through', 'entity2': 'needle'}, {'entity1': 'feces', 'relationship': 'squeezed out', 'entity2': 'abdomen'}, {'entity1': 'abdominal cavity', 'relationship': 'closed', 'entity2': 'cecum'}]"
22,"Similar procedures without ligation and puncture were used in the SHAM group. For the CLP+Eup group, the mice were administered Eupatilin (10mg/kg) by gavage 2 hours before operation. After surgery, each mouse was immediately resuscitated by subcutaneous injection of 1 mL warm saline.","[{'entity1': 'procedures', 'relationship': 'used', 'entity2': 'SHAM group'}, {'entity1': 'mice', 'relationship': 'administered', 'entity2': 'Eupatilin'}, {'entity1': 'mouse', 'relationship': 'resuscitated', 'entity2': 'saline'}]"
23,"The experimental samples were collected 24 hours after surgery. Besides, survival analysis was performed and lasted for 72 hours, with 10 mice per group, during which the mice were monitored every 6 hours and euthanized at the point of moribundity.","[{'entity1': 'samples', 'relationship': 'collected', 'entity2': 'surgery'}, {'entity1': 'survival analysis', 'relationship': 'performed', 'entity2': '72 hours'}, {'entity1': 'mice', 'relationship': 'monitored', 'entity2': 'hours'}, {'entity1': 'mice', 'relationship': 'euthanized', 'entity2': 'moribundity'}]"
24,"The lung tissue from three groups of mice were collected, fixed in 4% paraformaldehyde, dehydrated, embedded, and sliced into 4-μm-thick sections. Following the manufacturer’s instructions, the slices were stained by H&E staining kit.","[{'entity1': 'lung tissue', 'relationship': 'collected', 'entity2': 'groups'}, {'entity1': 'tissue', 'relationship': 'fixed in', 'entity2': 'paraformaldehyde'}, {'entity1': 'slices', 'relationship': 'stained by', 'entity2': 'H&E staining kit'}]"
25,"The severity of lung injury was evaluated based on inflammatory cell infiltration, edema and congestion. The pulmonary injury was scored as follows: 0 point for no injury, 1 point for <25% of the field injured, 2 points for 25% to 50% of the field injured, 3 points for 50% to 75% of the field injured, and 4 points for >75% of the field injured.","[{'entity1': 'severity', 'relationship': 'evaluated based on', 'entity2': 'inflammatory cell infiltration'}, {'entity1': 'pulmonary injury', 'relationship': 'scored as', 'entity2': 'points'}]"
26,"Immunohistochemical Assay The lung slices were dewaxed and rehydrated. Then, the antigen in slices was retrieved in citrate buffer (0.01 M, pH 6.0) for 10 minutes using a microwave oven, followed by quenching of endogenous peroxidase for 15 minutes.","[{'entity1': 'lung slices', 'relationship': 'retrieved in', 'entity2': 'citrate buffer'}, {'entity1': 'slices', 'relationship': 'quenched', 'entity2': 'peroxidase'}]"
27,The slices were blocked with 5% BSA for an hour. The slices were then incubated with rabbit anti-fibrinogen antibody overnight at 4°C. The slices were stained using a DAB kit and observed under a microscope.,"[{'entity1': 'slices', 'relationship': 'blocked', 'entity2': 'BSA'}, {'entity1': 'slices', 'relationship': 'incubated with', 'entity2': 'rabbit anti-fibrinogen antibody'}, {'entity1': 'slices', 'relationship': 'stained using', 'entity2': 'DAB kit'}]"
28,"The experiment was performed according to the manufacturer’s instructions. The catalog numbers for the reagent kits were as follows: IL-1β (Catalog No:70-EK201B), IL-6 (Catalog No:70-EK206) and TNF-α (Catalog No:70-EK282) from MultiScience, China.","[{'entity1': 'experiment', 'relationship': 'performed according to', 'entity2': 'manufacturer’s instructions'}, {'entity1': 'reagent kits', 'relationship': 'included', 'entity2': 'IL-1β'}, {'entity1': 'reagent kits', 'relationship': 'included', 'entity2': 'IL-6'}, {'entity1': 'reagent kits', 'relationship': 'included', 'entity2': 'TNF-α'}, {'entity1': 'reagent kits', 'relationship': 'from', 'entity2': 'MultiScience, China'}]"
29,"After measuring the protein concentrations using the BCA kit, lysates containing 20 µg protein samples were separated on 10% or 12.5% SDS-PAGE gels. The proteins were electrotransferred onto PVDF membranes in a cold condition.","[{'entity1': 'protein concentrations', 'relationship': 'measured using', 'entity2': 'BCA kit'}, {'entity1': 'lysates', 'relationship': 'separated on', 'entity2': 'SDS-PAGE gels'}, {'entity1': 'proteins', 'relationship': 'electrotransferred onto', 'entity2': 'PVDF membranes'}]"
30,"Plasminogen-activator inhibitor 1 (PAI-1) and key inflammation markers, ie, interleukin 6 (IL-6) and C-reactive protein (CRP), also play a role.","[{'entity1': 'Plasminogen-activator inhibitor 1', 'relationship': 'role', 'entity2': 'Inflammation'}, {'entity1': 'Interleukin 6', 'relationship': 'role', 'entity2': 'Inflammation'}, {'entity1': 'C-reactive protein', 'relationship': 'role', 'entity2': 'Inflammation'}]"
31,"Among proinflammatory cytokines contributing to IR development, the role of interleukin (IL)-6, which has autocrine and paracrine properties and is involved in insulin reception and free fatty acid (FFA) metabolism regulation, has been extensively studied.","[{'entity1': 'Interleukin 6', 'relationship': 'contributing', 'entity2': 'Insulin resistance'}, {'entity1': 'Interleukin 6', 'relationship': 'involved', 'entity2': 'insulin reception'}, {'entity1': 'Interleukin 6', 'relationship': 'involved', 'entity2': 'Dyslipidemia'}]"
32,"For cell immunofluorescence, macrophages were fixed with 4% paraformaldehyde for 10 min, permeabilized in 0.2% Triton X-100 for 15 minutes, and blocked in 5% BSA for 30 minutes.","[{'entity1': 'Macrophages', 'relationship': 'treatment', 'entity2': 'Paraformaldehyde'}, {'entity1': 'Macrophages', 'relationship': 'treatment', 'entity2': 'Triton X-100'}, {'entity1': 'Macrophages', 'relationship': 'treatment', 'entity2': 'BSA'}]"
33,"For tissue immunofluorescence staining, lung sections were treated the same way as for immunohistochemistry, then incubated with the F4/80 and TF primary antibodies overnight at 4°C.","[{'entity1': 'Lung sections', 'relationship': 'treatment', 'entity2': 'Immunohistochemistry'}, {'entity1': 'Lung sections', 'relationship': 'incubated with', 'entity2': 'F4/80'}, {'entity1': 'Lung sections', 'relationship': 'incubated with', 'entity2': 'TF'}]"
34,"Eupatilin Decreased the Expression of Inflammatory Cytokines and TF in LPS-Induced RAW264.7 Cells To explore the effect of Eupatilin, we measured inflammatory cytokines and TF levels in RAW264.7 cells six hours after LPS stimulation.","[{'entity1': 'Eupatilin', 'relationship': 'Decreased', 'entity2': 'Expression of Inflammatory Cytokines'}, {'entity1': 'Eupatilin', 'relationship': 'Decreased', 'entity2': 'TF'}, {'entity1': 'Eupatilin', 'relationship': 'Effect on', 'entity2': 'RAW264.7 Cells'}, {'entity1': 'Inflammatory Cytokines', 'relationship': 'Measured in', 'entity2': 'RAW264.7 cells'}, {'entity1': 'TF', 'relationship': 'Measured in', 'entity2': 'RAW264.7 cells'}, {'entity1': 'LPS', 'relationship': 'Induced', 'entity2': 'RAW264.7 Cells'}]"
35,"Eupatilin Regulated LPS-Induced Inflammation and Coagulation by Suppressing JAK2/ STAT3 Signaling Pathway in RAW264.7 Cells To observe whether Eupatilin-mediated effects on inflammation and coagulation were linked to the JAK2/STAT3 signaling pathway, we performed Western blot in RAW264.7 cells to detect the phosphorylation of target proteins.","[{'entity1': 'Eupatilin', 'relationship': 'Regulated', 'entity2': 'Inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'Regulated', 'entity2': 'Coagulation'}, {'entity1': 'Eupatilin', 'relationship': 'Linked to', 'entity2': 'JAK2/STAT3 signaling pathway'}, {'entity1': 'Eupatilin', 'relationship': 'Effects on', 'entity2': 'RAW264.7 Cells'}, {'entity1': 'Inflammation', 'relationship': 'Regulated by', 'entity2': 'Eupatilin'}, {'entity1': 'Coagulation', 'relationship': 'Regulated by', 'entity2': 'Eupatilin'}, {'entity1': 'JAK2/STAT3 signaling pathway', 'relationship': 'Linked to', 'entity2': 'Eupatilin'}, {'entity1': 'JAK2/STAT3 signaling pathway', 'relationship': 'Linked to', 'entity2': 'Inflammation'}, {'entity1': 'JAK2/STAT3 signaling pathway', 'relationship': 'Linked to', 'entity2': 'Coagulation'}, {'entity1': 'Inflammation', 'relationship': 'Linked to', 'entity2': 'JAK2/STAT3 signaling pathway'}, {'entity1': 'Coagulation', 'relationship': 'Linked to', 'entity2': 'JAK2/STAT3 signaling pathway'}]"
36,"Compared with the CON group, the LPS group had significantly higher expression levels of both p-JAK2 and p-STAT3. However, after pretreatment with Eupatilin, the expression levels of both p-JAK2 and p-STAT3 were diminished.","[{'entity1': 'CON group', 'relationship': 'comparison', 'entity2': 'LPS group'}, {'entity1': 'LPS group', 'relationship': 'higher expression levels', 'entity2': 'p-JAK2'}, {'entity1': 'LPS group', 'relationship': 'higher expression levels', 'entity2': 'p-STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'pretreatment', 'entity2': 'p-JAK2'}, {'entity1': 'Eupatilin', 'relationship': 'pretreatment', 'entity2': 'p-STAT3'}]"
37,"AG490 is an inhibitor of JAK2, which reduced the phosphorylation of JAK2 and STAT3. Western blot analysis revealed that AG490 inhibited the phosphorylation of both STAT3 and JAK2, while Eupatilin pretreatment strengthened this inhibition.","[{'entity1': 'AG490', 'relationship': 'inhibitor', 'entity2': 'JAK2'}, {'entity1': 'AG490', 'relationship': 'inhibitor', 'entity2': 'STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'strengthened inhibition', 'entity2': 'AG490'}, {'entity1': 'Eupatilin', 'relationship': 'strengthened inhibition', 'entity2': 'STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'strengthened inhibition', 'entity2': 'JAK2'}]"
38,"To verify whether Eupatilin pretreatment can reduce p-STAT3 nuclear translocation in LPS-stimulated RAW264.7 cells, both Western blot and immunofluorescence were performed. Western blot analysis showed that the pretreatment with Eupatilin attenuated the expression of p-STAT3 in nucleus.","[{'entity1': 'Eupatilin', 'relationship': 'pretreatment effect', 'entity2': 'p-STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'attenuated', 'entity2': 'p-STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'nuclear translocation reduction', 'entity2': 'p-STAT3'}, {'entity1': 'Eupatilin', 'relationship': 'nuclear translocation reduction', 'entity2': 'RAW264.7 cells'}]"
39,"Eupatilin Increased Survival Rate and Improved Inflammation and Coagulation in Septic Mice To investigate the effect of Eupatilin on the survival rate of septic mice, we established a model using CLP with C57BL/6 mice and calculated the 72-hour survival rate. The results showed that compared with SHAM group, the survival rate in CLP group dropped sharply. Moreover, compared to mice in CLP group, the survival rate in CLP+Eup group increased.","[{'entity1': 'Eupatilin', 'relationship': 'Increased', 'entity2': 'Survival Rate'}, {'entity1': 'Eupatilin', 'relationship': 'Improved', 'entity2': 'Inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'Improved', 'entity2': 'Coagulation'}, {'entity1': 'CLP group', 'relationship': 'dropped', 'entity2': 'Survival Rate'}, {'entity1': 'CLP+Eup group', 'relationship': 'increased', 'entity2': 'Survival Rate'}]"
40,"To explore whether Eupatilin improves inflammation and coagulation in mouse model, ELISA was performed. As anticipated, the level of inflammatory cytokines, such as TNF-α, IL-1β and IL-6, as well as coagulation factors, such as TF, TAT, PAI-1 and D-dimer, were lower in the plasma for mice in CLP+Eup group than those in the CLP group.","[{'entity1': 'Eupatilin', 'relationship': 'improves', 'entity2': 'Inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'improves', 'entity2': 'Coagulation'}, {'entity1': 'Inflammatory cytokines', 'relationship': 'lower', 'entity2': 'Plasma'}, {'entity1': 'Coagulation factors', 'relationship': 'lower', 'entity2': 'Plasma'}]"
41,"Plasma was decreased in the CLP group, while the pretreatment with Eupatilin reversed this trend.","[{'entity1': 'Plasma', 'relationship': 'decreased', 'entity2': 'CLP group'}, {'entity1': 'Eupatilin', 'relationship': 'reversed', 'entity2': 'trend'}]"
42,"Eupatilin Alleviated Pulmonary Inflammation and Lung Injury in Septic Mice. H&E staining revealed that in the CLP models, the alveolar wall was thickened, hyaline membranes were formed, and neutrophils had accumulated in the interstitial space.","[{'entity1': 'Eupatilin', 'relationship': 'Alleviated', 'entity2': 'Pulmonary Inflammation'}, {'entity1': 'Hyaline membranes', 'relationship': 'formed', 'entity2': 'CLP models'}, {'entity1': 'Neutrophils', 'relationship': 'accumulated', 'entity2': 'interstitial space'}]"
43,Eupatilin Reduced Coagulation and Fibrin Deposition in the Lung Tissue of Septic Mice. The exposure of TF is the way to promote coagulation.,"[{'entity1': 'Eupatilin', 'relationship': 'Reduced', 'entity2': 'Coagulation'}, {'entity1': 'TF', 'relationship': 'exposure', 'entity2': 'promote coagulation'}]"
44,Eupatilin Suppressed the Activation of JAK2/STAT3 Signaling Pathway in the Lung Tissue of Septic Mice. The Western blot analysis revealed that the expression of p-JAK2 and p-STAT3 was considerably higher in the CLP.,"[{'entity1': 'Eupatilin', 'relationship': 'Suppressed', 'entity2': 'Activation of JAK2/STAT3 Signaling Pathway'}, {'entity1': 'p-JAK2', 'relationship': 'higher', 'entity2': 'CLP'}]"
45,"To explore the effect of Eupatilin on JAK2/STAT3 pathway, we extracted proteins from the lung tissue of septic mice. The Western blot analysis revealed that the expression of p-JAK2 and p-STAT3 was considerably higher in the CLP group than in the SHAM group, and decreased with Eupatilin pretreatment.","[{'entity1': 'Eupatilin', 'relationship': 'effect on', 'entity2': 'JAK2/STAT3 pathway'}, {'entity1': 'Eupatilin', 'relationship': 'decreased', 'entity2': 'p-JAK2 expression'}, {'entity1': 'Eupatilin', 'relationship': 'decreased', 'entity2': 'p-STAT3 expression'}, {'entity1': 'p-JAK2', 'relationship': 'higher in', 'entity2': 'CLP group'}, {'entity1': 'p-STAT3', 'relationship': 'higher in', 'entity2': 'CLP group'}, {'entity1': 'Eupatilin', 'relationship': 'pretreatment', 'entity2': 'CLP group'}]"
46,"One of the pathological features of sepsis is the hyperactivation of inflammation and coagulation systems; both can promote and impact upon each other. In the present study, we found that Eupatilin reduced the expression of inflammatory factors and tissue factors in LPS-induced RAW264.7 cells in vitro and increased the survival of CLP mice.","[{'entity1': 'Sepsis', 'relationship': 'pathological feature', 'entity2': 'hyperactivation of inflammation'}, {'entity1': 'Sepsis', 'relationship': 'pathological feature', 'entity2': 'hyperactivation of coagulation'}, {'entity1': 'Eupatilin', 'relationship': 'reduced', 'entity2': 'expression of inflammatory factors'}, {'entity1': 'Eupatilin', 'relationship': 'reduced', 'entity2': 'expression of tissue factors'}, {'entity1': 'Eupatilin', 'relationship': 'increased', 'entity2': 'survival of CLP mice'}]"
47,"In vivo, Eupatilin attenuated lung injury and reduced inflammatory infiltration and coagulation activation in CLP mice. In summary, our research revealed that Eupatilin could protect septic mice from lung injury, by improving inflammation and coagulation, and that this protection was linked to JAK2/STAT3 signaling pathway.","[{'entity1': 'Eupatilin', 'relationship': 'attenuated', 'entity2': 'lung injury'}, {'entity1': 'Eupatilin', 'relationship': 'reduced', 'entity2': 'inflammatory infiltration'}, {'entity1': 'Eupatilin', 'relationship': 'reduced', 'entity2': 'coagulation activation'}, {'entity1': 'Eupatilin', 'relationship': 'protect', 'entity2': 'septic mice'}, {'entity1': 'Eupatilin', 'relationship': 'improving', 'entity2': 'inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'improving', 'entity2': 'coagulation'}, {'entity1': 'Eupatilin', 'relationship': 'linked to', 'entity2': 'JAK2/STAT3 signaling pathway'}]"
48,"Pro-inflammatory cytokines have the ability to stimulate coagulation in vitro. TF is the main factor in the coagulation process and is also a link between coagulation and inflammation. Under normal physiological conditions, monocytes, endothelial cells, and epithelial cells have low TF expression. However, during sepsis, these cells express and release TF into circulation after being stimulated by inflammatory factors and LPS.","[{'entity1': 'Pro-inflammatory cytokines', 'relationship': 'stimulate', 'entity2': 'coagulation'}, {'entity1': 'TF', 'relationship': 'main factor', 'entity2': 'coagulation process'}, {'entity1': 'TF', 'relationship': 'link', 'entity2': 'inflammation'}, {'entity1': 'monocytes', 'relationship': 'express', 'entity2': 'TF'}, {'entity1': 'endothelial cells', 'relationship': 'express', 'entity2': 'TF'}, {'entity1': 'epithelial cells', 'relationship': 'express', 'entity2': 'TF'}, {'entity1': 'sepsis', 'relationship': 'stimulate', 'entity2': 'TF'}, {'entity1': 'inflammatory factors', 'relationship': 'stimulate', 'entity2': 'TF'}, {'entity1': 'LPS', 'relationship': 'stimulate', 'entity2': 'TF'}]"
49,"After the release of TF, it binds to activated factor VII(VIIa), forming the TF–FVIIa complex, which can induce a pro-inflammatory response in macrophages. The TF–VIIa complex then activates factor X and initiates coagulation.","[{'entity1': 'TF', 'relationship': 'binds to', 'entity2': 'activated factor VII'}, {'entity1': 'TF', 'relationship': 'forms', 'entity2': 'TF-FVIIa complex'}, {'entity1': 'TF-FVIIa complex', 'relationship': 'induces', 'entity2': 'pro-inflammatory response'}, {'entity1': 'TF-FVIIa complex', 'relationship': 'activates', 'entity2': 'factor X'}, {'entity1': 'TF-FVIIa complex', 'relationship': 'initiates', 'entity2': 'coagulation'}, {'entity1': 'TF-FVIIa complex', 'relationship': 'activates', 'entity2': 'macrophages'}]"
50,"After the release of TF, it binds to activated factor VII(VIIa), forming the TF–FVIIa complex, which can induce a pro-inflammatory response in macrophages. The TF–VIIa complex then activates factor X and initiates coagulation activation. Factor Xa, together with factor Va, forms the prothrombinase complex, which subsequently converts prothrombin to thrombin. Thrombin then cleaves fibrinogen into fibrin, and fibrin degradation products can induce IL-6 production by monocytes in vitro. Moreover, fibrin degradation can elevate the levels of D-dimer. This process produces higher levels of PAI-1, and the overproduction of which will impair fibrinolysis. Increased fibrin formation due to impaired fibrinolysis causes organ injury and mortality in sepsis.","[{'entity1': 'TF', 'relationship': 'binds to', 'entity2': 'Factor VII(VIIa)'}, {'entity1': 'TF–FVIIa complex', 'relationship': 'induces', 'entity2': 'pro-inflammatory response'}, {'entity1': 'TF–VIIa complex', 'relationship': 'activates', 'entity2': 'Factor X'}, {'entity1': 'Factor Xa', 'relationship': 'forms', 'entity2': 'prothrombinase complex'}, {'entity1': 'prothrombinase complex', 'relationship': 'converts', 'entity2': 'prothrombin'}, {'entity1': 'Thrombin', 'relationship': 'cleaves', 'entity2': 'fibrinogen'}, {'entity1': 'fibrin degradation products', 'relationship': 'induces', 'entity2': 'IL-6 production'}, {'entity1': 'fibrin degradation products', 'relationship': 'elevate', 'entity2': 'D-dimer'}, {'entity1': 'fibrin formation', 'relationship': 'causes', 'entity2': 'organ injury'}, {'entity1': 'fibrin formation', 'relationship': 'causes', 'entity2': 'mortality'}]"
51,"According to a number of studies, the STAT3 signaling pathway can regulate inflammatory responses in LPS-induced macrophages and acute lung injury, including the production and release of inflammatory factors. In our previous study, we found that activation of the nuclear transcription factor STAT3 through phosphorylation at the tyrosine 705 site induced TF expression and facilitated the onset of coagulation dysfunction in sepsis. In addition, the use of the STAT3 inhibitor BP-1-102 decreased the expression of LPS-induced inflammatory cytokines such as IL-1β, IL-6, TNF-α, and TF in RAW264.7 cells. Similarly, our present experiments detected phosphorylation of STAT3 in both mice lung tissue and LPS-stimulated macrophages sepsis models, and increased intranuclear phosphorylation was found in macrophages, both of which are in agreement with previous studies.","[{'entity1': 'STAT3 signaling pathway', 'relationship': 'regulates', 'entity2': 'inflammatory responses'}, {'entity1': 'STAT3', 'relationship': 'induced', 'entity2': 'TF expression'}, {'entity1': 'STAT3', 'relationship': 'facilitated', 'entity2': 'coagulation dysfunction'}, {'entity1': 'STAT3 inhibitor BP-1-102', 'relationship': 'decreased', 'entity2': 'expression of LPS-induced inflammatory cytokines'}, {'entity1': 'STAT3', 'relationship': 'phosphorylation in', 'entity2': 'mice lung tissue'}, {'entity1': 'STAT3', 'relationship': 'phosphorylation in', 'entity2': 'LPS-stimulated macrophages'}, {'entity1': 'phosphorylation', 'relationship': 'found in', 'entity2': 'macrophages'}]"
52,"Studies have shown that Eupatilin is a selective PPARα-receptor agonist, the activation of PPARα may be related to the alleviation of inflammation and oxidative stress in LPS-induced ALI. Eupatilin has also been found to reduce the expression of inflammatory cytokines by inhibiting toll-like receptor 4 (TLR4). However, whether it has specific receptors requires further study. In addition, Eupatilin may also play a role in other pathways, such as PI3K/AKT, NF-κB, MAPK and Nrf2 pathways. Thus, whether these pathways also play a role in regulating inflammation and coagulation in sepsis needs further investigation. According to one study, Eupatilin can lower the expression of inflammatory mediators by inhibiting the NF-κB signaling pathway in endotoxin-stimulated macrophages. However, the specific mechanism of its regulation of macrophages and its effect on pathogens has not been elucidated yet.","[{'entity1': 'Eupatilin', 'relationship': 'is', 'entity2': 'PPARα-receptor agonist'}, {'entity1': 'Eupatilin', 'relationship': 'reduces', 'entity2': 'expression of inflammatory cytokines'}, {'entity1': 'Eupatilin', 'relationship': 'inhibiting', 'entity2': 'toll-like receptor 4 (TLR4)'}, {'entity1': 'Eupatilin', 'relationship': 'inhibiting', 'entity2': 'NF-κB signaling pathway'}, {'entity1': 'Eupatilin', 'relationship': 'lowers', 'entity2': 'expression of inflammatory mediators'}]"
53,"In our study, we found that the effect of Eupatilin pretreatment on the expression of inflammatory cytokines and tissue factors was consistent in both in vitro and in vivo experiments. Eupatilin-mediated effects in vivo were maintained in both plasma and lung tissues. Moreover, the inhibition of the JAK2/STAT3 signaling pathway was observed in both lung tissue and cells after Eupatilin pretreatment. Similar to Eupatilin, another plant-based molecule, piperlongumin, also has","[{'entity1': 'Eupatilin pretreatment', 'relationship': 'affects', 'entity2': 'expression of inflammatory cytokines and tissue factors'}, {'entity1': 'Eupatilin-mediated effects', 'relationship': 'maintained in', 'entity2': 'plasma and lung tissues'}, {'entity1': 'inhibition of JAK2/STAT3 signaling pathway', 'relationship': 'observed in', 'entity2': 'lung tissue and cells'}, {'entity1': 'piperlongumin', 'relationship': 'similar to', 'entity2': 'Eupatilin'}]"
54,Eupatilin can reduce the expression of inflammatory cytokines and coagulation factors in both RAW264.7 macrophages and mouse sepsis models.,"[{'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'inflammatory cytokines'}, {'entity1': 'Eupatilin', 'relationship': 'reduce', 'entity2': 'coagulation factors'}, {'entity1': 'RAW264.7 macrophages', 'relationship': 'model', 'entity2': 'Eupatilin'}, {'entity1': 'mouse sepsis models', 'relationship': 'model', 'entity2': 'Eupatilin'}]"
55,"The mechanism for this may involve the inhibition of JAK2/STAT3 activation and the reduction of p-STAT3 nuclear translocation, thereby regulating inflammatory cytokines and coagulation factors.","[{'entity1': 'mechanism', 'relationship': 'involve', 'entity2': 'inhibition of JAK2/STAT3 activation'}, {'entity1': 'mechanism', 'relationship': 'involve', 'entity2': 'reduction of p-STAT3 nuclear translocation'}, {'entity1': 'inflammatory cytokines', 'relationship': 'regulating', 'entity2': 'mechanism'}, {'entity1': 'coagulation factors', 'relationship': 'regulating', 'entity2': 'mechanism'}]"
56,Plasminogen activator inhibitor 1 (PAI-1) plays a role in inflammation and coagulation disorders caused by sepsis.,"[{'entity1': 'Plasminogen activator inhibitor 1', 'relationship': 'role', 'entity2': 'inflammation'}, {'entity1': 'Plasminogen activator inhibitor 1', 'relationship': 'role', 'entity2': 'coagulation disorders'}, {'entity1': 'sepsis', 'relationship': 'cause', 'entity2': 'inflammation'}, {'entity1': 'sepsis', 'relationship': 'cause', 'entity2': 'coagulation disorders'}]"
57,The pathogenesis of sepsis and potential therapeutic targets.,"[{'entity1': 'Pathogenesis', 'relationship': 'of', 'entity2': 'Sepsis'}, {'entity1': 'Therapeutic targets', 'relationship': 'potential', 'entity2': 'Sepsis'}]"
58,Monocytes/macrophages and sepsis.,"[{'entity1': 'Monocytes/macrophages', 'relationship': 'and', 'entity2': 'Sepsis'}]"
59,Inflammation and coagulation.,"[{'entity1': 'Inflammation', 'relationship': 'and', 'entity2': 'Coagulation'}]"
60,TMEM173 drives lethal coagulation in sepsis.,"[{'entity1': 'TMEM173', 'relationship': 'drives', 'entity2': 'coagulation'}, {'entity1': 'TMEM173', 'relationship': 'drives', 'entity2': 'sepsis'}]"
61,Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.,"[{'entity1': 'lipopolysaccharide', 'relationship': 'role', 'entity2': 'blood coagulation'}, {'entity1': 'lipopolysaccharide', 'relationship': 'role', 'entity2': 'inflammation'}, {'entity1': 'cecal ligation', 'relationship': 'role', 'entity2': 'blood coagulation'}, {'entity1': 'cecal ligation', 'relationship': 'role', 'entity2': 'inflammation'}]"
62,Eupatilin alleviates lipopolysaccharide-induced acute lung injury by inhibiting inflammation and oxidative stress.,"[{'entity1': 'Eupatilin', 'relationship': 'alleviates', 'entity2': 'acute lung injury'}, {'entity1': 'Eupatilin', 'relationship': 'inhibiting', 'entity2': 'inflammation'}, {'entity1': 'Eupatilin', 'relationship': 'inhibiting', 'entity2': 'oxidative stress'}]"
63,Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation.,"[{'entity1': 'Phospho-Tyr705', 'relationship': 'therapeutic target', 'entity2': 'Sepsis'}, {'entity1': 'Phospho-Tyr705', 'relationship': 'regulating', 'entity2': 'Inflammation'}, {'entity1': 'Phospho-Tyr705', 'relationship': 'regulating', 'entity2': 'Coagulation'}]"
64,Piperlongumin improves survival in the mouse model of sepsis: effect on coagulation factors and lung inflammation.,"[{'entity1': 'Piperlongumin', 'relationship': 'improves', 'entity2': 'Survival'}, {'entity1': 'Piperlongumin', 'relationship': 'effect on', 'entity2': 'Coagulation factors'}, {'entity1': 'Piperlongumin', 'relationship': 'effect on', 'entity2': 'Lung inflammation'}]"
65,Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation.,"[{'entity1': 'Ghrelin', 'relationship': 'protects', 'entity2': 'Alveolar macrophages'}, {'entity1': 'Ghrelin', 'relationship': 'suppresses', 'entity2': 'Lung inflammation'}]"
66,Bidirectional relation between inflammation and coagulation.,"[{'entity1': 'Inflammation', 'relationship': 'relation with', 'entity2': 'Coagulation'}]"
67,Tissue factor as a link between inflammation and coagulation.,"[{'entity1': 'Tissue factor', 'relationship': 'link between', 'entity2': 'Inflammation'}, {'entity1': 'Tissue factor', 'relationship': 'link between', 'entity2': 'Coagulation'}]"
68,Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure.,"[{'entity1': 'Bacterial endotoxin', 'relationship': 'activates', 'entity2': 'coagulation cascade'}, {'entity1': 'Bacterial endotoxin', 'relationship': 'exposure', 'entity2': 'phosphatidylserine'}, {'entity1': 'Gasdermin D', 'relationship': 'dependent', 'entity2': 'phosphatidylserine'}]"
69,Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.,"[{'entity1': 'Interleukin 6', 'relationship': 'attenuates', 'entity2': 'coagulation activation'}, {'entity1': 'Interleukin 6', 'relationship': 'experimental', 'entity2': 'endotoxemia'}, {'entity1': 'Chimpanzees', 'relationship': 'experimental', 'entity2': 'endotoxemia'}]"
70,Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.,"[{'entity1': 'Tissue factor gene', 'relationship': 'regulation', 'entity2': 'monocyte procoagulant response'}, {'entity1': 'Monocyte', 'relationship': 'response', 'entity2': 'endotoxin'}]"
71,The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.,"[{'entity1': 'Tissue factor messenger RNA', 'relationship': 'kinetics', 'entity2': 'human endotoxemia'}, {'entity1': 'Tissue factor messenger RNA', 'relationship': 'activation', 'entity2': 'coagulation'}]"
72,Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.,"[{'entity1': 'Microparticle', 'relationship': 'induction', 'entity2': 'intravascular tissue factor'}, {'entity1': 'Cell', 'relationship': 'induction', 'entity2': 'intravascular tissue factor'}, {'entity1': 'Intravascular tissue factor', 'relationship': 'associated', 'entity2': 'human endotoxemia'}]"
73,Hepatic acute phase proteins are regulated by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling.,"[{'entity1': 'Hepatic acute phase proteins', 'relationship': 'regulated by', 'entity2': 'IL-6'}, {'entity1': 'Hepatic acute phase proteins', 'relationship': 'regulated by', 'entity2': 'IL-1-type cytokines'}, {'entity1': 'IL-6', 'relationship': 'involving', 'entity2': 'STAT3'}, {'entity1': 'STAT3', 'relationship': 'crosstalk with', 'entity2': 'NF-κB-dependent signaling'}]"
74,STAT3 plays a role in the systemic inflammation of cancer cachexia.,"[{'entity1': 'STAT3', 'relationship': 'role in', 'entity2': 'systemic inflammation'}, {'entity1': 'cancer cachexia', 'relationship': 'inflammation of', 'entity2': 'systemic'}]"
75,Eupatilin attenuates the inflammatory response induced by intracerebral hemorrhage through the TLR4/MyD88 pathway.,"[{'entity1': 'Eupatilin', 'relationship': 'attenuates', 'entity2': 'inflammatory response'}, {'entity1': 'inflammatory response', 'relationship': 'induced by', 'entity2': 'intracerebral hemorrhage'}, {'entity1': 'intracerebral hemorrhage', 'relationship': 'through', 'entity2': 'TLR4/MyD88 pathway'}]"
